The hidden costs and characteristics of childhood rotavirus emergency visits in Canada

Pediatric Infectious Disease Journal

Volumn 31, Issue 2, 2012, Pages 159-161

  Le Saux, Nicole ^a   Bettinger, Julie ^b   Déry, Pierre ^c   Embree, Joanne ^d   Vaudry, Wendy ^e   Halperin, Scott A ^f   McDermid, Andrew ^g   Booth, Timothy F ^g   Coyle, Doug ^h  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Emergency department; Healthcare costs; Morbidity; Rotavirus; Societal costs

Indexed keywords

ARTICLE; CANADA; CHILD; CLINICAL FEATURE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIARRHEA; EMERGENCY WARD; FECES ANALYSIS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; ROTAVIRUS INFECTION; VIRAL GASTROENTERITIS; VOMITING;

CANADA; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FECES; FEMALE; GASTROENTERITIS; HEALTH EXPENDITURES; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS;

EID: 84858154416     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182375011     Document Type: Article

References (25)

1. Vesikari T, Itzler R, Matson DO, et al. Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis. 2007;11(suppl 2):S29 -S35.
2. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299 -305.
3. Wang FT, Mast TC, Glass RJ, et al. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics. 2010;125:e208-e213.
4. Begue RE, Perrin K. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice. Pediatrics. 2010;126:e40-e45.
5. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125:e199-e207.
6. Yee EL, Staat MA, Azimi P, et al. Burden of rotavirus disease among children visiting pediatric emergency departments in Cincinnati, Ohio, and Oakland, California, in 1999-2000. Pediatrics. 2008;122:971-977.
7. Ford-Jones EL, Wang E, Petric M, et al. Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med. 2000;154:586 -593.
8. Cortes JE, Curns AT, Tate JE, et al. Trends in healthcare utilization for diarrhea and rotavirus disease in privately insured US children <5 years of age, 2001-2006. Pediatr Infect Dis J. 2009;28:874-878.
9. Pont SJ, Grijalva CG, Griffin MR, et al. National rates of diarrhea-associated ambulatory visits in children. J Pediatr. 2009;155:56-61.
10. Widdowson MA, Meltzer MI, Zhang X, et al. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics. 2007;119:684-697. (Pubitemid 46556667)
11. Scheifele DW, Halperin SA. Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety. Semin Pediatr Infect Dis. 2003;14:213-219. (Pubitemid 36994974)
12. Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol. 2004;31:259-265. (Pubitemid 39371057)
13. Simmonds MK, Armah G, Asmah R, et al. New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol. 2008;42:368 -373.
14. Ontario Ministry of Health and Long-Term Care. Ontario health insurance (OHIP) schedule of benefits and fees. Toronto, Ontario, Canada: Ontario Ministry of Health and Long-Term Care; 2011.
15. Sumner A, Coyle D, Mitton C, et al. Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis. Pediatrics. 2010;126:623-631.
16. Coyle D, Coyle K, Bettinger JS, et al. Cost effectiveness of infant vaccination for rotavirus in Canada. Can J Infect Dis Med Microbiol. In press.
17. Statistics Canada. Average earnings by sex and work pattern. Statistics Canada 2011. Available at: http://www40.statcan.ca/l01/cst01/labor01aeng.htm. Accessed August 15, 2011.
18. Le Saux N., Bettinger JA, Halperin SA, et al. Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals. Pediatr Infect Dis J. 2010;29:879-882.
19. Brisson M, Senecal M, Drolet M, et al. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J. 2010;29:73-75.
20. Pont SJ, Carpenter LR, Griffin MR, et al. Trends in healthcare usage attributable to diarrhea, 1995-2004. J Pediatr. 2008;153:777-782.
21. Flores AR, Szilagyi PG, Auinger P, et al. Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States. Pediatrics. 2010;125:e191- e198.
22. Mast TC, Walter EB, Bulotsky M, et al. Burden of childhood rotavirus disease on health systems in the United States. Pediatr Infect Dis J. 2010;29:e19-e25.
23. Mast TC, Muro-Mercon C, Kelly CM, et al. The impact of rotavirus gastroenteritis on the family. BMC Pediatr. 2009;9:11.
24. Wang FT, Mast TC, Glass RJ, et al. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics. 2010;125:e208-e213.
25. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J. 2011;30(suppl 1):S56 -S60.